行情

ATRC

ATRC

AtriCure
NASDAQ

实时行情|Nasdaq Last Sale

27.89
-0.16
-0.55%
盘后: 27.66 -0.23 -0.82% 16:00 11/11 EST
开盘
27.95
昨收
28.05
最高
28.18
最低
27.60
成交量
10.02万
成交额
--
52周最高
34.39
52周最低
22.57
市值
11.03亿
市盈率(TTM)
-43.9005
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ATRC 新闻

  • Edited Transcript of ATRC earnings conference call or presentation 30-Oct-19 8:30pm GMT
  • Thomson Reuters StreetEvents.5天前
  • 沪指高开震荡 美股三大指数再创历史新高
  • 新浪财经.6天前
  • 监管机构:波音737 MAX有望明年一季度重返欧洲市场
  • 新浪美股.6天前
  • 跟谁学Q3收入增长近5倍 连续第六个季度实现盈利
  • 新浪财经.6天前

更多

所属板块

医疗设备、用品及经销
-0.11%
医疗设备和用品
+0.01%

热门股票

名称
价格
涨跌幅

ATRC 简况

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. It has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion. The Company also sells Lumitip dissectors and the Estech line of reusable cardiac surgery (valve) instruments. Its cryoICE cryosurgery product line offers various cryoablation devices. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA).
展开

Webull提供AtriCure Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。